Literature DB >> 10900163

Deficiency of human complement factor I associated with lowered factor H.

G M Naked1, M P Florido, P Ferreira de Paula, A M Vinet, J S Inostroza, L Isaac.   

Abstract

Deficiencies of factor I and/or factor H result in an increased consumption of C3 and higher susceptibility to recurrent infections. Here we describe a case of human factor I deficiency and lowered factor H levels. C3 concentration was 50% lower than normal, the classical pathway-dependent hemolytic activity was reduced to almost 30% of normal, and alternative pathway-dependent activity was completely absent. The killing by peripheral leukocytes of Candida albicans treated with deficient serum and the production of complement-dependent chemotactic factors were reduced in the proband's serum when compared with normal serum. Finally, we observed that C3 antigen present in the proband's serum has a different electrophoretic mobility than native C3 (most likely C3b), confirming the deregulation of complement activation due to the lack of regulatory proteins factors I and H. The impaired complement system described in this case, the first of its kind described in a Chile, explains the higher susceptibility to infections found in the proband. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10900163     DOI: 10.1006/clim.2000.4878

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  14 in total

1.  Attenuation of renal ischemia and reperfusion injury by human adrenomedullin and its binding protein.

Authors:  Kavin G Shah; Derry Rajan; Asha Jacob; Rongqian Wu; Kambhampaty Krishnasastry; Jeffrey Nicastro; Ernesto P Molmenti; Gene F Coppa; Ping Wang
Journal:  J Surg Res       Date:  2010-04-24       Impact factor: 2.192

2.  Recurrent infections in partial complement factor I deficiency: evaluation of three generations of a Brazilian family.

Authors:  A S Grumach; M F Leitão; V G Arruk; M Kirschfink; A Condino-Neto
Journal:  Clin Exp Immunol       Date:  2006-02       Impact factor: 4.330

3.  Simple method to distinguish between primary and secondary C3 deficiencies.

Authors:  Marlene Pereira de Carvalho Florido; Patrícia Ferreira de Paula; Lourdes Isaac
Journal:  Clin Diagn Lab Immunol       Date:  2003-03

4.  Peripheral administration of human adrenomedullin and its binding protein attenuates stroke-induced apoptosis and brain injury in rats.

Authors:  Wayne W Chaung; Rongqian Wu; Youxin Ji; Zhimin Wang; Weifeng Dong; Cletus Cheyuo; Lei Qi; Xiaoling Qiang; Haichao Wang; Ping Wang
Journal:  Mol Med       Date:  2011-06-17       Impact factor: 6.354

5.  Factor I autoantibodies in patients with atypical hemolytic uremic syndrome: disease-associated or an epiphenomenon?

Authors:  David Kavanagh; Isabel Y Pappworth; Holly Anderson; Christine M Hayes; Iain Moore; Eva-Maria Hunze; Karim Bennaceur; Pietro Roversi; Susan Lea; Lisa Strain; Roy Ward; Nick Plant; Corina Nailescu; Timothy H J Goodship; Kevin J Marchbank
Journal:  Clin J Am Soc Nephrol       Date:  2012-01-05       Impact factor: 8.237

6.  Human adrenomedullin and its binding protein attenuate organ injury and reduce mortality after hepatic ischemia-reperfusion.

Authors:  Juntao Yang; Rongqian Wu; Xiaoling Qiang; Mian Zhou; Weifeng Dong; Youxin Ji; Corrado P Marini; Thanjavur S Ravikumar; Ping Wang
Journal:  Ann Surg       Date:  2009-02       Impact factor: 12.969

7.  Role of complement in host defense against pneumococcal otitis media.

Authors:  Vishakha Sabharwal; Sanjay Ram; Marisol Figueira; In Ho Park; Stephen I Pelton
Journal:  Infect Immun       Date:  2009-01-12       Impact factor: 3.441

Review 8.  Mutations of complement factor I and potential mechanisms of neuroinflammation in acute hemorrhagic leukoencephalitis.

Authors:  Lori Broderick; Chhavi Gandhi; James L Mueller; Christopher D Putnam; Katayoon Shayan; Patricia C Giclas; Karin S Peterson; Seema S Aceves; Robert M Sheets; Bradley M Peterson; Robert O Newbury; Hal M Hoffman; John F Bastian
Journal:  J Clin Immunol       Date:  2012-08-29       Impact factor: 8.317

Review 9.  Translational mini-review series on complement factor H: renal diseases associated with complement factor H: novel insights from humans and animals.

Authors:  M C Pickering; H T Cook
Journal:  Clin Exp Immunol       Date:  2008-02       Impact factor: 4.330

10.  Molecular characterization of homozygous hereditary factor I deficiency.

Authors:  G V Baracho; V Nudelman; L Isaac
Journal:  Clin Exp Immunol       Date:  2003-02       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.